Biden-Harris Administration Announces Action to Increase Access to Sickle Cell Disease Treatments

The Biden-Harris Administration announced today that sickle cell disease (SCD) will be the first focus of the Cell and Gene Therapy (CGT) Access Model

Related Keywords

United States ,Americans ,Xavier Becerra ,Liz Fowler ,Centers For Medicare Medicaid Service ,Biden Harris Administration ,Human Services ,Department Of Health ,Innovation Center ,Gene Therapy ,Access Model ,Black Americans ,President Biden ,Medicaid Service ,Gene Therapy Access Model ,